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Abstarct
Background: Twenty four hour Holter monitoring (HM) in an early post-implantation
period in asymptomatic patients is considered as class IIb according to the ACC/AHA guide-
lines. It seems that post-implantation assessment extended by 24 hour HM in these patients
might shorten hospitalization and increase safety of these patients. This aspect has not been
widely discussed so far. The aim of our study was to evaluate pacing and sensing disturbances
in asymptomatic patients with proper parameters of single and double chamber pacemakers.
Methods: Studied group included 236 patients implanted with Biotronik Actros S (single
chamber) (group I — 130 patients) and Biotronik Actros D or Axios D (group II — 106 patients)
pacemakers. In all the patients 24 hour HM was performed 1–6 days after implantation (mean 3.4)
in order to assess all pacing and sensing disturbances.
Results: Sensing disturbances were found in 2 patients from group I and 22 patients from
group II (the most frequent pacemaker failure was atrial undersensing followed by ventricular
oversensing-T wave stering). In 1 patient from group I atrial failure to pace was observed. In
whole group pacing/sensing disturbances were found in 23% of patients, nevertheless they did
not provoke any hemodynamic consequences.
Conclusions: In an early post-implantation period pacemaker disturbances occur in 23% of
asymptomatic patients being more frequent in patients with dual chamber pacemaker. Atrial
undersensing and ventricular oversensing are the most common disturbances, nevertheless
having no hemodynamic consequences they are not life-threatening. Detection of these episodes
in an early post-implantation period allows for early change in pacemakers’ parameters and
thus decreasing risk of rehospitalization. We confirmed the low usefulness of HM in patients
with single chamber pacemaker early after implantation. (Folia Cardiol. 2006; 13: 390–395)
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Introduction
According to AHA/ACC standards in asymptoma-
tic pacemaker patients in an early post-implantation
period, performing the 24-hour ECG Holter monito-
ring (HM) is considered as class IIb indication for this
testing [1]. It is an alternative or a supplement to
constant telemetric monitoring. A class IIb means
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that research results or experts’ opinions are not ful-
ly supportive wilt little usefulness of this procedure.
Modern pacemakers and endocardial electro-
des are devices of great reliability, comparing to
those from the very beginnings of electrotherapy
[2–7]. On the other hand, major technological pro-
gress, new algorithms of pacemaker function, new
advanced functions and growing expectations to
their operating not only as pacing devices cause that
the ACC/AHA guidelines from 6 years ago may be
partially no longer up-to-date and the diagnostic
spectrum of HM may be widened [8]. Apart form
therapeutic aspects, costs play a progressively lar-
ger role in patient’s management [9, 10]. One of
their major components is the length of the hospi-
talization period, the shortening of which, remaining
safe for the patient after the pacemaker implanta-
tion, may be an important factor in lowering them.
Owing to that, new methods of evaluating patient’s
condition in the early post-implantation period are
being considered, proving pacemaker’s correct pa-
cing and sensing [11]. Until now, methods used to
assess stimulating devices, such as standard
12-lead ECG, control of the parameters of stimu-
lation, radiography not always have revealed po-
ssible malfunctioning of pacing devices [12]. It
seems that widening the routine evaluation of the
patient’s condition in the early post-implantation
period in asymptomatic patients with HM may
shorten the hospitalization period and improve
patient’s safety.
The aim of this study was to evaluate of pacing
and sensing of pacemakers in 24-hour HM in the
early post-implantation period, in asymptomatic pa-
tients with correct parameters of the implanted sin-
gle and double chamber pacemakers.
Methods
Initially, 236 patients, who had pacemakers
implanted in the years 1998–2002 in the Department
of Cardiology and Cardiosurgery of the Medical
University of Lodz, were included in the study.
The patients were divided into two groups: group I
— 130 patients with implanted Actros S (Biotronik)
single chamber pacemaker, group II — 106 patients
with implanted Actros D (R) or Axios D (R) double
chamber pacemaker. The clinical characteristics is
shown in Table 1.
Implantation procedure
The implantations were performed by expe-
rienced physicians (over 500 performed operations)
in accordance with the Polish Cardiological Society
standards [13]. Every patient had a passive fixation
electrode implanted: Synox SX 53–JPB into right
atrium, and Synox 60–BP into the appendage of the
right ventricle. Double punction (one for every elec-
trode) of left subclavian vein was the method of cho-
ice in implantation.
The correct positioning of the electrodes was
assessed using radiologic examination (radiogra-
phy). Intra cardial ECG (IEGM), with the so-called
“intrinsic deflection” performed in every patient,
was an additional criterion of correct electrode
fixation.
The following electrical parameters, measured
with Biotronik ERA 300 analyzer, were considered
correct during the implantation procedure:
— threshold of stimulation both in atrium and in
ventricle, with impulse width of 0.5 ms: < 0.5 V;
— amplitude of P wave measured in bipolar confi-
guration: > 3 mV in five subsequent complexes;
— amplitude of R wave measured in bipolar confi-
guration: >10 mV in five subsequent complexes.
Resistance measuring was performed using
Biotronik PMS 1000 programming device.
After connecting electrodes to the stimulator,
with original factory settings and in magnetic rhy-
thm, ECG record from limb leads I, II, III was per-
formed and the correctness of pacing and sensing
was analysed.
Table 1. Clinical characteristics of studied patients.
Feature Group I (n = 130) Group II (n = 100)
Men 56 (43%) 58 (58%)
Age (years) 52–86 (mean: 72 ± 7) 52–78 (mean: 67.5 ± 7.3)
Left ventricle ejection fraction 39–81% (mean: 61% ± 18%) 42–74% (mean: 56 ± 12%)
Indications for implantation
Sick sinus syndrome 0 52 (52%)
Atrio-ventricular misconduction 0 43 (43%)
Persistent atrial fibrillation 130 (100%) 0
Other 0 5 (5%)
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In the period from 24 hours to 5 days (av. 3.2 ±
± 1.3 days) after implantation, using PMS 1000 pro-
gramming device, the parameters of stimulation
were evaluated, considering correct:
— threshold of stimulation in atrium with impul-
se width 0.4 ms: < 1.5 V;
— threshold of stimulation in venrticle with im-
pulse width 0.4 ms: < 1 V;
— average amplitude value of P wave measured
for 12 s in subsequent complexes: > 2 mV;
— average amplitude value of R wave measured
for 12 s in subsequent complexes: > 8 mV;
— electrode resistance from 300 to 1500 Ohm.
The parameters of pacing were measured in
unipolar configuration, and parameters of sensing
in bipolar. Only patients with correct parameters
were included in the study. The settings of the sti-
mulator after implantation is shown in Table 2.
To assess correct sensing intracardial electro-
cardiogramm from atrial and ventricular channel
was performed.
24-hour Holter ECG monitoring
In every patient in the period between 1 and
6 days (av. 3.4 ± 1.2 days) after implantation 24-hour
HM was performed, with accordance to ACC/AHA
standards.
Registration was performed using 3-channel
Oxford MR 45-3 registrating devices with pacing
option (on analog recording tapes TDK AD 60)
using typical leads CS-2, CM-5 and IS. The analy-
sis of registration was performed using Oxford
Medilog Excel 3 system, applying automatic analy-
sis using stimulator programme and manual record
verification. The commonly accepted analysis stan-
dards according to ACC/AHA guidelines were used.
In HM record pacing and sensing evaluation
was performed. The disturbances found were clas-
sified according to the following parameters: all
pacing and sensing disturbances, failure to pace,
failure to sense. The latter were divided into: over-
sensing and undersensing.
Failure to pace was stated when the effective
stimulation did not occur behind stimulator peak;
undersensing — stimulator peaks behind the peak
of P wave and/or behind R wave in QRS complex;
oversensing — too long peak-to-peak period (lon-
ger than basic pacemaker rhythm).
Results
Pacing and sensing parameters
in early post-operation period
Into the final analysis, 230 patients were inc-
luded: 130 patients from group I and 100 patients
form group II, with correct pacing and sensing pa-
rameters. From 6 patients not included in the stu-
dy, 4 had stimulation threshold over 1.5 V, in the
remaining 2 the average P wave potential was un-
der 2.0 mV. In the remaining patients, both in gro-
up I and II, correct pacing and sensing values were
found. Those parameters in both post-implantation
groups are shown in Table 3.
Evaluation of pacing and sensing disturbances
in 24 hour ECG Holter monitoring
Tables 4 and 5 show the evaluation of pacing
and sensing disturbances in patients with implan-
ted single and double chamber pacemakers in ear-
ly post-implantation period. In group I sensing
Table 2. Programmed parameters of single and double chamber pacemakers in an early post-implanta-
tion period.
Parameter Programming Programming
method group I  method group II
Modes of pacing Ventricle pacing mode Double chamber pacing mode
Basic pacing frequency 80/min 60/min or 70/min
Histeresis Off Off
Amplitude of the impulse in atrial and 3.6 V 3.6 V
ventricular channel with impulse width of 0.4 ms
Atrium sensing Does not occur 0,5 mV
Ventricle sensing 2.5 mV 2.5 mV
Atrial refraction period Does not occur 450 ms
Ventricular refraction period 250 ms 250 ms
Upper rate Does not occur 120/min
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disturbances characterized as undersensing and
oversensing were found overall in two patients. In
none of the patients insufficient or missing ventri-
cular stimulation was found.
In 12 patients from group II, despite the fact
that standard sensing was set in bipolar configura-
tion, undersensing-type disturbances of P wave were
found. The most often found sensing disturbance in
this group in ventricular channel was oversensing
— sensing with T wave. That caused transitional
bradycardia with pacemaker function pauses with
maximum of up to 1600 ms, with no clinical symp-
toms. Those disturbances appeared in different time
of the day, regardless of patient’s activity.
There were no pacing disturbances found
in ventricular channel, only in 1 patient failure to
pace in the atrium was found — in only 4 subsequ-
ent complexes, followed by effective ventricular
pacing.
Despite the fact that the above mentioned
disturbances were found overall in 23% of patients,
they did not cause pauses with hemodynamic after-
effects.
Discussion
Performing Holter monitoring in asymptoma-
tic patients with implanted pacemaker was subject
to only few publications [15–17]. It was proved in
most of them that in patients with VVI pacemakers
and unipolar electrodes disturbances in stimulating
devices functioning may be found, amongst which
oversensing was the most common. This phenome-
non was observed despite the fact that correct pa-
cing and sensing parameters were confirmed [18].
It needs to be stated that this research was perfor-
med in the long term after implantation (av.
3.5 years). However, there is a lack of publications
assessing the function of single and double cham-
ber pacemakers in the early post-implantation pe-
riod. This may happen for two different reasons:
first, introducing bipolar electrodes was supposed
to eliminate oversensing problem completely — the
most common cause of sensing disturbances in pa-
tients with unipolar electrodes, second, the ACC/AHA
guidelines for evaluating asymptomatic patients
using Holter monitoring, published in 1999 and va-
lid to this day, were classified as IIb — that means
that the opinion of most experts was not supporti-
ve for performing HM in such circumstances. Con-
sequently, this issue was beyond the interests of
most researchers.
We were convinced to perform this research
in patients with implanted single chamber pacema-
ker by the need of assessing whether introducing
Table 3. Pacing and sensing parameters in an early post-implantation period in patients with one and
double chamber pacemakers.
Group I Group II
Atrium pacing threshold [V] Does not occur 0.64 ± 0.43
Ventricle pacing threshold [V] 0.61 ± 0.6 0.62 ± 0.5
P wave amplitude [mV] Does not occur 3.1 ± 1.1
R wave amplitude [mV] 12 ± 5.2 14.4 ± 6
Atrial electrode impedance [Ohm] Does not occur 752 ± 335
Ventricular electrode impedance [Ohm] 684 ± 256 705 ± 428
Table 4. Pacing and sensing disturbances in
patients with single chamber pacemaker found
during 24 h Holter monitoring in an early post-
-implantation period — group I (n = 130).
Failure to sense: oversensing — ventricle 1 (0.8%)
Failure to sense: undersensing — ventricle 1 (0.8%)
Failure to pace — ventricle 0
Disturbances overall 2 (1.5%)
Table 5. Pacing and sensing disturbances in pa-
tients with double chamber pacemaker found
during 24 h Holter monitoring in an early post-
-implantation period — group II (n = 100).
Failure to sense: oversensing
atrium 0 (0%)
ventricle 10 (10%)






Disturbances overall 23 (23%)
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bipolar electrode really eliminates the problem of
sensing disturbances, described in such a high per-
centage in patients with VVI pacemakers and uni-
polar electrodes.
Today’s double chamber pacemakers are devi-
ces with many programmable functions and com-
plex diagnostical algorhythms. This validates the
question whether the parameters of pacing and sen-
sing, programmed in standard manner after the pro-
cedure, ensure correct pacemaker function and pa-
tient’s safety. It is the matter of major importance
in search of the methods for shortening hospitali-
zation period and therefore lowering the costs of
management. Because of low availability of constant
telemetric monitoring methods, HM may be an ef-
ficent alternative in the early evaluation of the pa-
tient after PM implantation. In our study HM sho-
wed differences in the number of pacing and sen-
sing disturbances in both groups. They were
sporadic in group I (only 2 patients — 1.6%) but in
group II they occured in 23% of patients.
In both groups, in none of the patients distur-
bances in chamber stimulation were found. Incor-
rect pacemaker function did not cause relevant pau-
ses and therefore would not have been an obstacle
for safely discharging a patient from hospital in the
early post-operation period.
In group I patients, under- and oversensing in-
cidents were sporadic, they occured in only 2 pa-
tients. It has confirmed the opinion that introducing
bipolar electrodes significantly decreased the pre-
valence of sensing disturbances. In our study, qu-
oted before, concerning oversensing was found in
3.6% of asymptomatic patients with VVI pacema-
kers with unipolar electrodes. Moreover, those di-
sturbances lead to occurence of pauses in pacema-
ker function — with maximum up to 2600 ms. In
group II undersensing in atrium channel was found
in 12% of patients. Also other publications confir-
med that undersensing in atrium channel is the
most common sensing disturbance [19]. In our pa-
tients, the sensitivity in atrium channel of 0.5 mV
allowed lowering this value to 0.1 mV. Then, ho-
wever, the risk of occuring atrial oversensing
must be taken into account [20, 21]. Intra cardiac
electrograms (IEGM) are required to assess sen-
sing when lowering the value of this parameter.
Oversensing in ventricular channel was found in
10% of patients. The longest pause registered
was 1600 ms.
It is well known that the oversensing pheno-
menon in ventricular channel may result in slowing
pacing frequency and be the reason of unnecessary
hospitalization because of suspecting pacemaker
malfunction. Finding of these disturbances, thanks
to HM, in early post-implantation period allows
changing pacemaker parameters (by correcting re-
fraction period and/or sensing) and therefore avo-
iding a next hospitalization. In the group of patients
taken into account, no atrial oversensing or ventri-
cular undersensing was found.
It needs to be emphasised that all disturban-
ces found in HM were not a danger to the patient’s
life and/or health. All of the disturbances found
were managed by correcting pacemaker parame-
ters. Proper functioning of PM was then confirmed
in the next Holter examination.
The topic of this study has never been discus-
sed in the available literature. This evaluation is the
first try of analysing of usefullness of 24-hour ECG
in assessing the correctness of pacing in asympto-
matic patients in the early pacemaker post-implan-
tation period. The urge to discharge the patient from
hospital as early as possible after pacemaker im-
plantation is due to lowering the costs of hospitali-
zation, and full safety of those patients must be
ensured. This forces using new diagnostic features
which give greater feeling of safety both to the pa-
tient and to the physician who decides to shorten
the hospitalization period after the pacemaker im-
plantation procedure.
The results of our study proved only a slight
value of 24-hour HM in asymptomatic patients with
single chamber pacemakers and bipolar electrodes,
which is in accordance to ACC/AHA guidelines
(class IIb).
However, conclusions different than the men-
tioned above come from evaluating the patients with
double chamber pacing. In this group HM in the
early post-implantation period revealed sensing di-
sturbances, the correction of which, although they
did not endanger patients’ life and/or health, allo-
wed better programming of the pacemaker and avo-
iding possible hospitalization because of sensing
disturbances.
Therefore, it seems to be reasonable to consi-
der performing 24 hour HM in asymptomatic pa-
tients with double chamber pacemaker, in early
post-implantation period.
Paradoxally, introducing further pacemaker
functions may lead to increasing the percentage of sen-
sing disturbances, undetectable in routine contol but
only in HM. Moreover, the optimal individualization
of pacemaker parameter is possible mostly on the
basis of Holter ECG examination.
Perfecting diagnostic function in pacemakers
may allow in the future to register IEGM and there-
fore to limit the legitimacy of HM in those patients.
395
Jerzy K. Wranicz et al., 24 hour Holter monitoring in patients in post-implantation period
www.foliacardiologica.eu
References
1. Crawford MH., Bernstein SJ., Deedwania PC et al.
ACC/AHA guidelines for ambulatory electrocardio-
graphy executive summary and recommendations:
a report of the American College of Cardiology/
/American Heart Association Task Force on Practice
Guidelines (Committee to Revise the Guidelines for
Ambulatory Electrocardiography). Circulation 1999;
100: 886–893.
2. Furman S, Hayes DL, Homes DR. Telemetry.
A practice of cardiac pacing, 3rd Ed. Futura Publish-
ing; Mt Kisco, NY 1993; 633.
3. Lascault G, Frank R, Himbert C et al. Diagnosis of
ventricular tachycardia using a pacemaker Holter func-
tion. Pacing Clin Electrophysiol, 1994; 17: 1316–1319.
4. Levine PA, Sanders R, Rankowitz HT. Pacemaker
diagnostics: measured data, event marker, electrogram,
and event counter telemetry. In: Ellenbogen KA,
Kay GN eds. Clinical cardiac pacing. WB Saunders
Co; Philadelphia, PA 1995; 639–655.
5. Ovsyshcher IE. Cardiac arrhythmias and device ther-
apy: results and perspectives for the new century.
Futura Publishing Co, Armonk, NY 2000; 44: 357–364.
6. Lazarus A, Mugica J. Advances in lead technology,
from recent advances in cardiac pacing, Vol. 4 edited
by Barold SS, Mugica J. Futura Publishing Co, Ar-
monk, NY 1998; 16: 337–356.
7. Igidbashian D, Scalise T, Igidbashian S. Unipolar
leads: advantages and limits. Mediterran J Pacing
Electrophysiol, 1999; 4: 251–254.
8. Szafraniec Z, Wranicz JK, Chudzik M, Cygankiewicz I,
Goch JH. 24-godzinne badanie elektrokardiografic-
zne metodą Holtera: wskazania, zastosowanie. Folia
Cardiol, 2005; 3: 153–160.
9. Bernstein AD, Irwin ME, Personnet V et al. Raport
of the NASPE Policy Conference on antibradycardia
pacemaker follow up: effectiveness, needs and re-
usorces. Pacing Clinical Electrophysiol, 1994; 17:
1714–1729.
10. Fraser JD, Gillis AM, Irwin ME, Nishimura S, Tyers GF,
Philippon F. Guidelines for pacemaker follow up in
Canada: a consensus statement of the Canadian
Working Group on Cardiac Pacing. Can J Cardiol,
2000; 16: 355–376
11. Chudzik M, Wranicz JK, Goch JH, Bednarkiewicz Z,
Krzemińska-Pakuła M. Wczesna ocena pacjentów
z implantowanym dwujamowym stymulatorem serca.
Pol Przegl Kardiol, 2005; 7: 55–61.
12. Chudzik M, Wranicz JK, Goch JH, Futyma M. Czy
możliwe jest bezpieczne skrócenie czasu hospitaliza-
cji w ośrodku wysokospecjalistycznym u pacjentów
po implantacji stymulatora dwujamowego serca. Fo-
lia Cardiol, 2005; 3: 140–146.
13. Świątecka G, Bieganowska K, Kargul W, Kornacewicz-
-Jach Z, Kutarski A, Lewicka-Nowak E, Lubiński A,
Musiał W, Piwowarska W, Prochaczek F, Sadowski Z,
Trusz-Gluza M, Walczak F, Wojciechowski D. Stan-
dardy elektrostymulacji serca 1999 (www: ptkardio.pl).
14. ACC/AHA guidelines for ambulatory electrocardio-
graphy: Executive summary and recommendations.
Circulation, 1999; 100: 886–947.
15. Pavlovic SU, Kocovic D, Djordievic M, Belkic K,
Kaostic D, Velimirovic D. The etiology of syncope in
pacemaker patients. Pacing Clin Electrophysiol,
1991; 14: 2086–2091.
16. Djordievic M, Jelitz V, Velimirovic D. The usefulness
of Holter monitoring in pacemaker patients. Pacing
Clinical Electrophysiol, 1985; 8: A23 (abstract).
17. Wranicz JK, Strzondała M, Zrobek J, Ruta J, Krekora J,
Maciejewski M. 24-hours ECG Holter monitoring
— detection of asymptomatic stimulation disturbances
in patients with artificial pacemakers. Med Sci Monit,
1999; 5: 262–264.
18. Wranicz JK, Chudzik M, Cygankiewicz I. Wartość
24-godzinnego monitorowania EKG metodą Holtera
w rutynowej kontroli asymptomatycznych pacjentów
z wszczepionymi stymulatorami VVI. Folia Cardiol,
2001; 8: A-31–A-34.
19. Wiegand U, Bonnemeier H, Bode F et al. Continu-
ous holter telemetry of atrial electrograms and mark-
er annotations using a common holter recording sys-
tem: impact on Holter electrocardiogram interpreta-
tion in patients with dual chamber pacemakers.
Pacing Clin Electrophysiol, 2002; 25: 1724–1730.
20. Brandt J, Worzewski W. Far field QRS complex sens-
ing: prevelance and timing with bipolar atrial leads.
Pacing Clin Electrophysiol, 2000; 23: 315–320.
21. Brouwer J, Nagelkerke D, Heijer P. Analysis of
atrial sensed far field ventricular signals: a reas-
sessment. Pacing Clin Electrophysiol, 1997; 20:
916–922.
